Idexx Laboratories (IDXX) Operating Expenses (2009 - 2026)

Idexx Laboratories' Operating Expenses history runs 18 years deep, the most recent figure standing at $360.2 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 17.37% year-over-year to $360.2 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 7.09% YoY), while the FY2025 annual figure was $1.3 billion, up 3.91% from the prior year.
• Operating Expenses was $360.2 million for Q1 2026 at Idexx Laboratories, up from $342.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $360.2 million in Q1 2026 to a low of $114.8 million in Q1 2023.
• Historically, Operating Expenses has averaged $236.4 million across 5 years, with a median of $292.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses plunged 33.48% in 2023, then soared 160.96% in 2024.
• A 5-year view of Operating Expenses shows it stood at $126.5 million in 2022, then increased by 9.78% to $138.8 million in 2023, then soared by 122.55% to $309.0 million in 2024, then rose by 10.85% to $342.5 million in 2025, then gained by 5.15% to $360.2 million in 2026.
• The last three Operating Expenses figures came in at $360.2 million (Q1 2026), $342.5 million (Q4 2025), and $328.5 million (Q3 2025), per Business Quant data.